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Conclusions: Overall there were no differences in the ACE genotype
frequency between the different groups. However, women with FH and AMI
had the same ACE gene pattern which clearly differed from normals. We
have previously found that women with acute Ml who die during one year
follow-up have very high DD frequency (46%), ID (42%) and II (27%). This
very large group of FH patients needs to be followed in order tostudywhether
ACE gene polymorphism also here is related to mortality.
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ReductaeeGeneIe NotAssociatedWithIncreased
RiakforCoronaryArteryDiseaaeor Myocardiat
Infarction
J.L. Anderson, G.J. King, M.J. Thompson, M. Todd, T.L. Bair,
J.B. Muhlestein, J.F. Carlquist. Urriversityof Utah and LDS FfospitaLSalt
Lake CiM UT USA
Elevated plasma homocysteine has been identified as a risk faotor for
ooronaty atherosclerosis. Homocyateinemia results from a deficiency of
methylenetetrahydrofolate raductase (MTHFR) activity which is instrumen-
tal in the conversion by methylation of homoeysteine to methionine. A mild
MTHFRdeficienoy whiChisaesoeiatad with athermolabile form of the enzyme
has raoently been asaoeiated with increased risk for coronary artery disease
(CAD). In other studies, thermolabile MTHFR has also been shown to be
linked to a Cm to T transition in the MTHFR gene. We therefore examined
whether the C8m to T transition was asaociatad with risk for CAD or my-
oeardial infarction (Ml). Blood was drawn from patients undergoing coronary
eatheterization and DNAextraotad bya phenol-chloroform method. Genotyp-
ing was done by PCR amplification of a 198 bp segment of the MTHFR gene
that brackets nt677. The amplioon was digeated with the restriction enzyme
Hinrlwhich recognizes asitecreatad bythe Cto Tsubstitution. Prcducfawere
visualized by elacfrophoresis in 2% agarose with ethidium bromide staining.
Coronav angiograms were read blinded to genotype results.Among patients
(n= 521) with severe CAD (>60% stenosis) the mutant allele frequency was
34.6% compared with 35.6% for individuals with <10% stenosis (n= 166) (p
= NS); 13.3% of patients compared with 14.0%of controls wera homozygous
for the mutation (p= NS). Among patients with a diagnosis of Ml (n= 167)
the mutant allele frequency waa 33.3% compared with 32.0% for controls
(n = 572) (p= NS): homozygoaity among patients and controls was 11.2%
and 11.0%, reapeotively (p = NS). Thus, patients with angiographic CAD or
clinical Ml do not show an increased frequency of the Cen to T mutation in
MTHFR. Our findings do not SUPPOIIthis mutation as the basis for increased
risk for CAD or Ml associated with homoeysteinemia.
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n7235 Angiotensin-Convertin9EnzymeGanotypesandRiskfor MyocardialInfarctioninWomen
J.L. Anderson, J.F. Carlquist, G.J. King, L. Morrison, M.J. Thompsen,
E. Ludwig, J.B. Muhlestein, T.L. Bair, R.H. Ward. Urriversityof Utah and
LDS Hospital, Salt Lake City UT USA, Urrivereifyof Oxford, Oxford, UK
The human angiotensin-convertin9 enzyme (ACE) occurs in two polymor-
phic forms: an insartion (1)allele which carries an inserted 267 base pair
AhJelement and a deletion (D) allele characterized by the absence of this
element. Homozygosity for the D allele has been variously associated with
rnyooardial infarction (Ml), coronary artery disease (CAD) and idiopathic di-
lated cardiomyopathy in predominantly male populations. We tested for an
increased association between this ACE polymorphism and Ml in a sample
comprised exclusively of women. Forthisstudy, genomic DNA waa extracted
using a phenoUchloroform method and precipitated with isopropanol. The
ACE alleles were identified by the amplified fragment length polymorphism
(AFLP) method which uses primeratobracket the insertion region in intron 16
and the polymeraae chain reaction (PCR) to produce either a 490 bp product
(1allele) or a 190 bp product (D allele). Products were elecfrophoresad on
a 1.5% agarose gel and visualized by ethidium bromide staining. There was
a significant increase in the frequenoy of the DD genotype among women
who had a previous Ml (n = 141) compared with matched oontrols without
Ml (with or without CAD; n = 323) (39.0% vs 29.0%, p < 0.05; relative risk
(RR) = 1.55). In contrast, the D allele was found in combination with the I
allele somewhat more frequently among controls than patients (46.0% vs
39.0%, RR= 0.69, p < 0.03) suggesting a possible protective effect for the
heterozygous (ID) veraus homozygous (DD) genotype. The frequencies of
the II genotype were similar fOr patients and controls (21.9% and 22.9%,
respectively; RR = 0.95). Consistent with findings in male-dominated popu-
Iationa, our results associate the ACE DD genotype with increased risk for
Ml in women. In contrast to other repotis, the ID phenotype did not confer
risk and tended to be protective, a finding that will require confirmation.
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BarumLavelaofTransformingGrowthFactor-Bets1
(TGF-@)ia DepreaaadinWomenWithCoronary
ArteryDiseese
M.A. Amine, L.T. Clark, O.A. Batuman. SUNYHes/tfr Science
Center at Brookfyrr,NY USA
The antiinflammatory cytokine TGF-pl is produced by all cell types within
the vascular wall, in a latent form that required bioaotivation by proteolysia,
or acidification in vitro. In this study the clinioal relevance of TGF-pl in
CAD was studied by correlating its serum levels with the extent of ooronary
arteiy disease in 61 conaeeutive females (age 40-76) with angiographieally
defined CAD stratified as involving: Ovessels (n = 21, mean age 61.5), or
1-2 vessels (n = 21, mean age 62.1), or 3 veaaela (n = 19 patients, mean
age 61.6). Venous blood was obtainad fasting, immediately prfor to cardiac
cath, and active and total TGF~-1 in serum and plasma were measured
by ELISA. Active TGF-ISI levels were always <5pg/ml. Total (aotive+latent)
TGF-pl was determined after acid activation of samples and serum and
plasma levels showed a significant correlation. Mean aerum TGF-A91levels
in O, 1-2, and 3 vessel CAD groups were 76.2 * 31.1 (=t SD), 64 * 19.5,
and 58.7 + 26.9, respectively. Difference between serum TGF-~1 Ievela of
patients with no CAD, and with CAD, was significantly different (t = 2.39,
p < 0.020). Difference between TGF-~1 levels in patients with no CAD,
and 3 vessel CAD was alao significant (t = 2.17 p < 0.03L We found a
negative cxmelationbetwwn: 1) serum TGF-j31 levels and presence of CAD
(r= –0.31, p < 0.022) (Spearman’s rank correlation). We did not observe a
correlation between serum TGF-pl levels and serum l-p(a), Apo B, Apo Al,
trfglycerfdes,HDLC, LDLC, total cholesterol, orexiatenoeof unstable angina.
We eondude that depressed Ievela of serum TGF-@l in CAD correlate with
diaease severity.
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PolymorphismInvolvedinCardiovascular
Complicationsin EssentialHypartanaion?
M.L. De Buyzere, B.B. Wuyts, J.R. Delanghe, D.A. Duprez,
G. Leroux-Reels, D.L. Clement. University Hoepite/ Gent, Belgium
DD-genotypa of the insertionldeletion (l/D) polymorphism of theangiotensin-l
converting enzyme (ACE) has been incriminated to be a potent risk factor in
ischemic heart diseaae. On theotherhand, recant Iiteraturewas unable to link
(1/D)-ACE polymorphism with essential hypertension, (HT). Therefore, we
aimed to study frequenoy of (1/D)-ACE genotypes in target organ damage in
easential HT.A group of 305 patients was enrolled (166 males, 137 females,
age 55 & 13 years). one hundred and five patients (34.3%), had a DD-
genotype, 144 (47.3%) a D1-genotypaand 56 patients (16.4%) a H-genotype.
The D-allele frequeney of 0.66 was comparable with D-allele frequenoy
(0.61) in a control group of 115 healthy subjeefs from the same region. Table
summarizes age, detection of hypertension, number of antihypartenaive drug
classes needed to reduce BP to -=95 mmHg, left ventricular hypertrophy
(LVH), infarction (AMI) and ACE activity for the three genotypes.
Table DD (n = 105) DI (n= 144) II (n = 56)
Age (years) 55* 13 54* 13 57 i 13
Age at detection(yr) 464c 12 44* 12 47* 13
Number of drugclasses 1.9+ 0.6 1.9 +0,9 1.9 i f.o
LVH (“A) 28 43 20
AM (“/0) 34 54 12
ACE activ~(U/L) (* p < 0.01) 71 & 24* 57527 40& 24
The higher ACE activity in DD-genotypa is in agreement with eartier
findings.
In conclusion, DD-genotype of the (1/D)-ACEpolymotphiam was not over-
represented in cardiovascular complications in essential hypertension.
